FDA gives a priority review for key heart failure drug Farxiga
January 6, 2020Sales and Marketing AstraZeneca, Heart Failures, farxiga
The FDA has accepted a New Drug Application (sNDA) and has granted a priority review for AstraZeneca’s drug Farxiga (dapagliflozin) …
Mysterious viral pneumonia infects dozens in central China, bird flu and SARS ruled out
January 6, 2020Sales and Marketing Bird Flu, China, Sars, WHO, World Health Organisation, Wuhan, pneumonia
A total of 59 cases of viral pneumonia have been reported in the city of Wuhan, with seven people in …
Incyte’s drug stumbles at Phase 3 in treatment-naive acute graft-versus-host disease
January 6, 2020Research and Development, Sales and Marketing Incyte, pharma, trial failure
Drugmaker Incyte has made it known that its selective JAK1 inhibitor therapy itacitinib fell short at Phase 3 in the …
AstraZeneca’s drug Lokelma approved in China
January 6, 2020Sales and Marketing AstraZeneca, China, FDA, eu commission, kidney failure, potassium
AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …
Novo Nordisk to offer US patient’s in immediate need free insulin
January 3, 2020Medical Communications Novo, Novo Nordisk, Type 1 diabetes, diabetes, insulin, type 2 diabetes
Novo Nordisk said it would offer free, one-time supply of insulin to those in need, amidst rising insulin prices. Novo …
Single cycle of chemo is just as effective as two in treating testicular cancer, study finds
January 3, 2020Medical Communications Cancer, Men's Cancer, chemo, chemotherapy, testicular cancer
A new study shows that testicular cancer can be successfully treated with less rounds of chemotherapy. The recent study, published …
NICE rules against the use of Akcea’s Waylivra in the NHS
January 3, 2020Medical Communications Akcea, European Commission, FCS, NHS, NICE
NICE has not recommended Akcea’s drug Waylivra (volanesorsen) to be used for the treatment of Familial Chylomicronaemia Syndrome (FCS) in …
Johnson & Johnson sued by Washington State for role in the opioid crisis
January 3, 2020Medical Communications Bernie Sanders, Johnson & Johnson, OxyContin, fentanyl, opioid crisis, opioids
The state of Washington sued pharmaceutical company Johnson & Johnson for deceptive marketing that said their opioids were effective for …
FDA approves artificial pancreas developed by the University of Virginia
January 2, 2020Business Services, Medical Communications FDA, Pancreas, Type 1 diabetes, diabetes, insulin, type 2 diabetes
The FDA has approved an artificial pancreas system based on technology from the University of Virginia’s Center for Diabetes Technology. …
AI is more accurate than doctors at diagnosing breast cancer, study finds
January 2, 2020Business Services AI, AI Cancer, AI Trials, AI diagnoses, AI in clinical trials, Cancer, breast cancer
A recent study showed that Artificial Intelligence is more accurate than doctors in diagnosing breast cancer from mammograms. The research …
China approves 13-valent pneumonia vaccine
January 2, 2020Business Services Chinese Pharma, Pneumonia China, pneumonia, pneumonia vaccine
China’s National Medical Products Administration (NMPA) has approved the launch of the country’s first self-developed 13-valent pneumonia vaccine to protect …
Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020
January 2, 2020Business Services Bernie Sanders, President trump, Presidential Election, Trump, Trump Drugs, drug prices
Multiple drugmakers, including Pfizer, Sanofi and GlaxoSmithKline, plan to increase US list prices on more than 200 drugs in the …
FDA fuelled opioid crisis by failing to police pharmaceutical companies, new study shows
January 2, 2020Business Services FDA, Opioids Crisis, Opioids Trump, OxyContin, Trump Administration, opioids
The FDA’s Risk Evaluation and Mitigation Strategy (REMS), which began in 2012, failed to successfully police the companies creating opioids …
European Commission authorises Janssen’s anti-depressant Spravato
December 23, 2019Sales and Marketing Janssen, MDD, Nasal Spray, TRD, depression, mental health
The European Commission has approved Janssen’s nasal spray Spravato (esketamine), which is used to treat major depressive disorder (MDD) that …
AstraZeneca’s triple combination therapy for patients with COPD approved in China
December 23, 2019Sales and Marketing AstraZeneca, COPD, China, respiration
AstraZeneca has announced that budesonide-glycopyrroniunm-formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease …
NHS to fast track cannabis-based treatment for epilepsy
December 23, 2019Sales and Marketing CBD, CBD Oil, cannabis, drug treatment, epilepsy, thc
The NHS has fast-tracked the drug Epidyolex, a cannabidiol (CBD), to be available for epilepsy treatment through the NHS in …
FDA gives accelerated approval to AstraZeneca and Daiichi’s breast cancer drug
December 23, 2019Sales and Marketing AstraZeneca, Breast Cancer drug, Cancer, breast cancer, skin cancer
The FDA has approved the breast cancer drug Enhertu, developed by AstraZeneca and Daiichi Sankyo. José Basel, the Executive Vice …
Galderma Acne treatment receives approval from Europe
December 20, 2019Medical Communications Acne cream, Retinoid, acne
Galderma’s acne cream AKLIEF (trifarotene 50 mcg) has received approval by the European Union after reviewing its summary of product …
AstraZeneca sells Amrimidx and Casodex European rights to Juvisé Pharmaceuticals
December 20, 2019Medical Communications AstraZeneca, Cancer, Juvise, breast cancer, prostate cancer
AstraZeneca has announced that it has agreed to sell the rights to Arimidex (anastrozole) and Casodex (bicalutamide) in Europe, as …
FDA approves Merck & Co’s Ebola vaccine
December 20, 2019Medical Communications Ebola, Ebola Drug, Ebola West Africa, Ebola vaccine, Merck
The FDA has approved Merck & Co’s Ebola vaccine, Ervebo. This marks the first time they have approved a vaccine …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
